After reading general reactions of the BTD of CVD and Iconoclasts SA article, I think there is a second BTD coming for renal/CKD.

I think BTD serves more its purpose with a renal indication and by the SA article, it wasnt uncommon that a drug had 2 designations.

I would heat up the partnering or buyout talk even more.